Tolnaftate
NDC Package 61360-2020-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Tolnaftate is a medication not effective on the scalp or nails. Marketed by Sun Pharma Canada Inc., this product is identified by NDC 61360-2020 and is authorized under FDA application M005.

Identification & Billing

NDC Package Code
61360-2020-2
Package Description
1 TUBE in 1 CARTON / 30 g in 1 TUBE
Product Code
61360-2020
11-Digit Billing Format
61360202002

Clinical Specifications

Proprietary Name
Tolnaftate
Dosage Form
-
Usage Information
This product is not effective on the scalp or nails.

Regulatory & Marketing

Labeler Name
Sun Pharma Canada Inc.
FDA Application #
M005
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
08-20-2009
End Marketing Date
08-20-2009
Listing Expiration
08-20-2009
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 61360-2020-2 identifies a specific commercial package of 1 tube in 1 carton / 30 g in 1 tube of Tolnaftate, labeled by Sun Pharma Canada Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sun Pharma Canada Inc. on August 20, 2009. The current certification is valid through August 20, 2009.

How is this Sun Pharma Canada Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 61360202002. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
61360-2020-2
11-Digit CMS (5-4-2)
61360-2020-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.